James Brumley

James Brumley

InvestorPlace Feature Writer

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

AAPL: Apple Should Bear Fruit on Chinese Soil … For a While

By James Brumley, InvestorPlace Feature Writer

Chinese consumers love Apple products like the iPhone and the iPad, but here's what AAPL needs to know about selling electronic goods in China.

The Market Doesn’t Give Bonus Points to Martyrs

By James Brumley, InvestorPlace Feature Writer

Ronnie Moas has a great point about Amazon, Apple and Philip Morris being a stone's throw away from questionable business practices that test morality. Then again, name one company that isn't.

Monsanto Earnings Matter More Than GMO Worries

By James Brumley, InvestorPlace Feature Writer

Does the General Mills decision to remove bioengineered corn starch from it Cheerios recipe actually mean anything to Monsanto? Well, not nearly as much as earnings per share of MON stock means.

Sirius XM Is Facing Some Serious Competition

By James Brumley, InvestorPlace Feature Writer

Is the era of Sirius XM dominance in your car finally coming to a close now that Google and Apple, and technology, have opened a new door?

Chinese Love for U.S. Is Smothering American Companies

By James Brumley, InvestorPlace Feature Writer

Chinese companies want to acquire more and more U.S. companies, but more and more of these buyout efforts need to be quelled for the sake of maintaining competitiveness.

Twitter: Great Story or Not, TWTR Stock Has a Valuation Problem

By James Brumley, InvestorPlace Feature Writer

Twitter might be all the rage, but that doesn't necessarily make TWTR stock a good investment. Its way-too-frothy price is impossible to justify.

Horrible Bosses – The Worst 5 CEOs of 2013

By James Brumley, InvestorPlace Feature Writer

These five execs have left behind an ugly legacy, qualifying them as the worst CEOs of 2013. Unfortunately, some of them are still around to do more damage.

5 ‘Problem’ Stocks to Avoid in 2014

By James Brumley, InvestorPlace Feature Writer

While 2014 should be a decent year for the broader markets, you might be better off shirking these five stocks to avoid until things significantly change for each.

Gun Sales Spike Puts Pressure on Smith & Wesson, Ruger

By James Brumley, InvestorPlace Feature Writer

SWHC and RGR have had a great run, thanks to fear of stricter laws prodding gun sales. That was a once-in-a-decade prod, however, meanings the next few years could be lackluster.

5 Pharma Stocks to Buy for Big Dividends

By James Brumley, InvestorPlace Feature Writer

Drugmakers aren't known for big dividends, but the pharmaceutical industry can actually offer something for income investors.

Load More